Researchers have released findings from a large retrospective study showing that women treated for early stage HER2-positive breast cancer tumors ≤ 1cm have a significantly greater risk of recurrence than women whose tumors are HER2-negative.
Latest Conference Articles
Advertisement
When physicians first realize they are being sued for malpractice, they feel %u201Cshame, anger, depression, a loss of control, and a crisis of confidence."
Advertisement
A study reveals a beneficial effect of tamoxifen on breast cancer recurrences at 10 and 15 years of follow-up in women with ductal carcinoma in situ (DCIS).
Updates to the NCCN Prostate Cancer Guidelines were presented by James L. Mohler, MD.
Advertisement
Advertisement
Trending on HCPLive
1
Expert Insights: Recommendations on FH, Triglycerides in 2026 Dyslipidemia Guidelines
2
APEX: Zumilokibart Shows Durable Response at 52 Weeks in Atopic Dermatitis
3
ABCs in Dermatology: Previewing the 2026 AAD Annual Meeting
4
Behind the Guidelines: Top Clinical Takeaways From the 2026 Dyslipidemia Guidelines
5